Primary biliary cholangitis Trials in Paris, France
Conditions / Primary biliary cholangitis / Paris, France
Primary biliary cholangitis is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06488911 | To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate | TERMINATED | PHASE3 |
| NCT06051617 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | RECRUITING | — |
| NCT04620733 | RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) | COMPLETED | PHASE3 |
| NCT03394924 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis | COMPLETED | PHASE2 |
| NCT05050136 | A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis | RECRUITING | PHASE2 |
| NCT06051617 | Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | RECRUITING | — |
| NCT05014672 | A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness | COMPLETED | PHASE2 |
| NCT03602560 | ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) | COMPLETED | PHASE3 |
| NCT04594694 | Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC | TERMINATED | PHASE2 |
| NCT06675604 | LEOPARD Training and Validation Data Collection Study | RECRUITING | — |